806 related articles for article (PubMed ID: 26722422)
1. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
[TBL] [Abstract][Full Text] [Related]
3. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
4. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
8. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
[TBL] [Abstract][Full Text] [Related]
10. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.
Aversa I; Zolea F; Ieranò C; Bulotta S; Trotta AM; Faniello MC; De Marco C; Malanga D; Biamonte F; Viglietto G; Cuda G; Scala S; Costanzo F
J Exp Clin Cancer Res; 2017 Aug; 36(1):104. PubMed ID: 28774348
[TBL] [Abstract][Full Text] [Related]
12. Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells.
Zhao Z; Lu P; Zhang H; Xu H; Gao N; Li M; Liu C
Breast Cancer Res; 2014 Jul; 16(4):408. PubMed ID: 25056574
[TBL] [Abstract][Full Text] [Related]
13. LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway.
Xiao C; Wu CH; Hu HZ
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(13):2819-24. PubMed ID: 27424981
[TBL] [Abstract][Full Text] [Related]
14. Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients.
Wang D; Lu P; Zhang H; Luo M; Zhang X; Wei X; Gao J; Zhao Z; Liu C
Oncotarget; 2014 Nov; 5(21):10803-15. PubMed ID: 25301732
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer.
Shi R; Liu L; Wang F; He Y; Niu Y; Wang C; Zhang X; Zhang X; Zhang H; Chen M; Wang Y
Cell Signal; 2020 Dec; 76():109810. PubMed ID: 33069797
[TBL] [Abstract][Full Text] [Related]
16. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
17. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
18. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer.
Guo J; Fu Z; Wei J; Lu W; Feng J; Zhang S
Med Oncol; 2015 Jan; 32(1):393. PubMed ID: 25428393
[TBL] [Abstract][Full Text] [Related]
19. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
Yang Z; Ji L; Jiang G; Liu R; Liu Z; Yang Y; Ma Q; Zhao H
Biosci Trends; 2018; 12(1):40-46. PubMed ID: 29553100
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate (Chondroitin 4) Sulfotransferase-11-Mediated Induction of Epithelial-Mesenchymal Transition and Generation of Cancer Stem Cells.
Behrens A; Jousheghany F; Yao-Borengasser A; Siegel ER; Kieber-Emmons T; Monzavi-Karbassi B
Pharmacology; 2020; 105(5-6):246-259. PubMed ID: 32344408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]